Antagonist nanobodies prevent protease inhibition by CD109
K
Kathrine Tejlgård Jensen
A
Ana Viana Almeida
S
Sanne Rönning
M
Maximillian Karlander
N
Nadia Sukusu Nielsen
I
Ida B. Thøgersen
M
Magdalena Malm
G
Gregers Rom Andersen
J
Jan J. Enghild
J
Johan Rockberg
S
Seandean Lykke Harwood
Article Details
Journal
Journal of Biological Chemistry
Volume / Issue
Vol. 302, Issue 3
Published
March 01, 2026
Pages
111187
ISSN
0021-9258
Publisher
Elsevier BV
Authors (11)
K
Kathrine Tejlgård Jensen
A
Ana Viana Almeida
S
Sanne Rönning
M
Maximillian Karlander
N
Nadia Sukusu Nielsen
I
Ida B. Thøgersen
M
Magdalena Malm
G
Gregers Rom Andersen
J
Jan J. Enghild
J
Johan Rockberg
S
Seandean Lykke Harwood
Related Articles from this Journal
Asialoglycoprotein receptor subunit Asgr1a loss results in attenuated cholesterol absorption in zebrafish fed a western diet
Joshua T. Derrick, Tabea O.C. Moll et al.
Aug 2026
10.1016/j.jbc.2026.113239
Nrf2-mediated epigenetic priming of osmoprotective genes enhances cellular adaptation to hyperosmotic stress
Yi Lu, Na Li et al.
Aug 2026
10.1016/j.jbc.2026.113278
Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function
Kailash Venkatraman, Daniel Milshteyn et al.
Aug 2026
10.1016/j.jbc.2026.113306
Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression
Katerina-Marina Pilala, Artemis-Melina Papadimitriou et al.
Aug 2026
10.1016/j.jbc.2026.113302
Correction: Abstract 5588 Multifunctional carbon dots nanocarriers: Dual-drug delivery via π-π stacking interaction for stimuli-responsive chemotherapy and high oxidative stress
Girum Demissie, Jia Chang
Aug 2026
10.1016/j.jbc.2026.113253